Relationships of gut microbiota, short-chain fatty acids, inflammation, and the gut barrier in Parkinson's disease

被引:274
|
作者
Aho, Velma T. E. [1 ,2 ,3 ]
Houser, Madelyn C. [4 ,5 ]
Pereira, Pedro A. B. [1 ,2 ,3 ]
Chang, Jianjun [5 ]
Rudi, Knut [6 ]
Paulin, Lars [1 ]
Hertzberg, Vicki [4 ]
Auvinen, Petri [1 ]
Tansey, Malu G. [5 ,7 ]
Scheperjans, Filip [2 ,3 ]
机构
[1] Univ Helsinki, Inst Biotechnol, DNA Sequencing & Genom Lab, Viikinkaari 5D, Helsinki 00790, Finland
[2] Helsinki Univ Hosp, Dept Neurol, Ward K4A,Haartmaninkatu 4, FI-00290 Helsinki, Finland
[3] Univ Helsinki, Dept Neurol Sci Neurol, Ward K4A,Haartmaninkatu 4, FI-00290 Helsinki, Finland
[4] Emory Univ, Nell Hodgson Woodruff Sch Nursing, 1520 Clifton Rd, Atlanta, GA 30322 USA
[5] Emory Univ, Sch Med, Dept Physiol, 615 Michael St, Atlanta, GA 30322 USA
[6] Norwegian Univ Life Sci, Fac Chem Biotechnol & Food Sci KBM, N-1433 As, Norway
[7] Univ Florida, Dept Neurosci & Neurol, Ctr Translat Res Neurodegenerat Dis, Coll Med, 1149 Newell Dr, Gainesville, FL 32611 USA
基金
芬兰科学院;
关键词
Parkinson’ s disease; Microbiota; Intestine; Inflammation; Short-chain fatty acids; INTESTINAL INFLAMMATION; ALZHEIMERS-DISEASE; BRAIN AXIS; BIOMARKERS; ABERRATIONS;
D O I
10.1186/s13024-021-00427-6
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background Previous studies have reported that gut microbiota, permeability, short-chain fatty acids (SCFAs), and inflammation are altered in Parkinson's disease (PD), but how these factors are linked and how they contribute to disease processes and symptoms remains uncertain. This study sought to compare and identify associations among these factors in PD patients and controls to elucidate their interrelations and links to clinical manifestations of PD. Methods Stool and plasma samples and clinical data were collected from 55 PD patients and 56 controls. Levels of stool SCFAs and stool and plasma inflammatory and permeability markers were compared between patients and controls and related to one another and to the gut microbiota. Results Calprotectin was increased and SCFAs decreased in stool in PD in a sex-dependent manner. Inflammatory markers in plasma and stool were neither intercorrelated nor strongly associated with SCFA levels. Age at PD onset was positively correlated with SCFAs and negatively correlated with CXCL8 and IL-1 beta in stool. Fecal zonulin correlated positively with fecal NGAL and negatively with PD motor and non-motor symptoms. Microbiota diversity and composition were linked to levels of SCFAs, inflammatory factors, and zonulin in stool. Certain relationships differed between patients and controls and by sex. Conclusions Intestinal inflammatory responses and reductions in fecal SCFAs occur in PD, are related to the microbiota and to disease onset, and are not reflected in plasma inflammatory profiles. Some of these relationships are distinct in PD and are sex-dependent. This study revealed potential alterations in microbiota-host interactions and links between earlier PD onset and intestinal inflammatory responses and reduced SCFA levels, highlighting candidate molecules and pathways which may contribute to PD pathogenesis and clinical presentation and which warrant further investigation.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] Relationships of gut microbiota, short-chain fatty acids, inflammation, and the gut barrier in Parkinson’s disease
    Velma T. E. Aho
    Madelyn C. Houser
    Pedro A. B. Pereira
    Jianjun Chang
    Knut Rudi
    Lars Paulin
    Vicki Hertzberg
    Petri Auvinen
    Malú G. Tansey
    Filip Scheperjans
    Molecular Neurodegeneration, 16
  • [2] Parkinson's Disease Is Associated with Impaired Gut-Blood Barrier for Short-Chain Fatty Acids
    Yang, Xiaodong
    Ai, Penghui
    He, Xiaoqin
    Mo, Chengjun
    Zhang, Yi
    Xu, Shaoqing
    Lai, Yiqiu
    Qian, Yiwei
    Xiao, Qin
    MOVEMENT DISORDERS, 2022, 37 (08) : 1634 - 1643
  • [3] The role of gut-derived short-chain fatty acids in Parkinson's disease
    Saadh, Mohamed J.
    Mustafa, Anfal Nabeel
    Mustafa, Mohammed Ahmed
    Jyothi, S. Renuka
    Dabis, Hasan Khalid
    Prasad, G. V. Siva
    Mohammad, Imad Jassim
    Adnan, Ahmed
    Idan, Ameer Hassan
    NEUROGENETICS, 2024, 25 (04) : 307 - 336
  • [4] Short-chain fatty acids and gut microbiota in multiple sclerosis
    Melbye, Pernille
    Olsson, Anna
    Hansen, Tue H.
    Sondergaard, Helle B.
    Oturai, Annette Bang
    ACTA NEUROLOGICA SCANDINAVICA, 2019, 139 (03): : 208 - 219
  • [5] Gut Microbiota, Short-Chain Fatty Acids, and Herbal Medicines
    Feng, Wuwen
    Ao, Hui
    Peng, Cheng
    FRONTIERS IN PHARMACOLOGY, 2018, 9
  • [6] Mechanisms of Short-Chain Fatty Acids Derived from Gut Microbiota in Alzheimer's Disease
    Qian, Xiao-hang
    Xie, Ru-yan
    Liu, Xiao-li
    Chen, Sheng-di
    Tang, Hui-dong
    AGING AND DISEASE, 2022, 13 (04): : 1252 - 1266
  • [7] Associations of gut microbiota, dietary intake, and serum short-chain fatty acids with fecal short-chain fatty acids
    Yamamura, Ryodai
    Nakamura, Koshi
    Kitada, Naoya
    Aizawa, Tomoyasu
    Shimizu, Yu
    Nakamura, Kiminori
    Ayabe, Tokiyoshi
    Kimura, Takashi
    Tamakoshi, Akiko
    BIOSCIENCE OF MICROBIOTA FOOD AND HEALTH, 2020, 39 (01) : 11 - 17
  • [8] The Role of Short-Chain Fatty Acids of Gut Microbiota Origin in Hypertension
    Wu, Yeshun
    Xu, Hongqing
    Tu, Xiaoming
    Gao, Zhenyan
    FRONTIERS IN MICROBIOLOGY, 2021, 12
  • [9] Significance of Gut Microbiota and Short-Chain Fatty Acids in Heart Failure
    Zhao, Peng
    Zhao, Suhong
    Tian, Jinwei
    Liu, Xinxin
    NUTRIENTS, 2022, 14 (18)
  • [10] The role of short-chain fatty acids in microbiota–gut–brain communication
    Boushra Dalile
    Lukas Van Oudenhove
    Bram Vervliet
    Kristin Verbeke
    Nature Reviews Gastroenterology & Hepatology, 2019, 16 : 461 - 478